Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 84,948 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 84,948 shares of Tempus AI stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $70.02, for a total transaction of $5,948,058.96. Following the completion of the transaction, the chief executive officer now directly owns 5,208,057 shares in the company, valued at $364,668,151.14. This represents a 1.60 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Tempus AI Price Performance

NASDAQ:TEM opened at $89.44 on Friday. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm’s fifty day moving average is $46.60 and its two-hundred day moving average is $50.29.

Analyst Ratings Changes

Several research firms have issued reports on TEM. TD Cowen reaffirmed a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Needham & Company LLC reissued a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a report on Tuesday, January 14th. William Blair lowered shares of Tempus AI from an “outperform” rating to a “market perform” rating in a report on Wednesday. Loop Capital dropped their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Finally, Bank of America boosted their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $58.55.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently added to or reduced their stakes in the business. Comerica Bank boosted its holdings in Tempus AI by 342.5% in the fourth quarter. Comerica Bank now owns 112,145 shares of the company’s stock valued at $3,786,000 after purchasing an additional 86,800 shares during the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of Tempus AI in the fourth quarter worth about $348,000. Mission Creek Capital Partners Inc. acquired a new position in shares of Tempus AI in the fourth quarter worth about $1,612,000. Oxford Asset Management LLP acquired a new position in shares of Tempus AI in the fourth quarter worth about $457,000. Finally, Gilder Gagnon Howe & Co. LLC acquired a new position in shares of Tempus AI in the fourth quarter worth about $775,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.